Clinical significance of T-wave alternans in hypertrophic cardiomyopathy

Circulation Journal

Volumn 66, Issue 5, 2002, Pages 457-462

  Nami, Kuroda ^a   Yoshio, Ohnishi ^a   Akihiro, Yoshida ^a   Akinori, Kimura ^b   Mitsuhiro, Yokoyama ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Disarray; Hypertrophic cardiomyopathy; T wave alternans; Ventricular tachyarrhythmia

Indexed keywords

BINDING PROTEIN; CARDIAC MUSCLE BINDING PROTEIN C; MYOSIN HEAVY CHAIN; TROPONIN I; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; HEART MUSCLE BIOPSY; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; QT INTERVAL; SUDDEN DEATH; T WAVE;

AGED; CARDIAC COMPLEXES, PREMATURE; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FIBROSIS; HUMANS; HYPERTROPHY; MALE; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; TACHYCARDIA, VENTRICULAR;

EID: 0036260889     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.457     Document Type: Article

References (38)

1. Hypertrophic cardiomyopathy: Recent observations regarding the specificity of three hallmarks of the disease: Asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet
2. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy: A multicenter study
3. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
4. Prognosis in hypertrophic cardiomyopathy
5. Natural history of hypertrophic cardiomyopathy: A population-based study, 1976 through 1990
6. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy
7. Time-domain signal-averaged electrocardiogram in nonischemic ventricular tachycardia
8. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death
9. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
10. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study
11. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave altemans
12. Exercise-induced T-wave alternans as a marker of high risk in patients with hypertrophic cardiomyopathy
13. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
14. Determinant of microvolt-level T-wave alternans in patients with dilated cardiomyopathy
15. Electrical altemans and cardiac electrical instability
16. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy
17. Cardiac biopsy of Kawasaki disease
18. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
19. Signal-averaged electrocardiography in hypertrophic cardiomyopathy
20. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death
21. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death
22. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy
23. Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiologic findings
24. Microvolt T wave alternans in human cardiac hypertrophy: Electrical instability and abnormal myocardial arrangement
25. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation
26. Sudden cardiac death in hypertrophic cardiomyopathy
27. Hypertrophic cardiomyopathy: Histological features
28. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk
29. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy
30. Asymmetric apical hypertrophy: Ten years experience
31. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management part I and II
32. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of β-myosin heavy chain mutations
33. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
34. Arg→Gln mutation
35. Sudden death due to troponin T mutations
36. Novel missense mutation in cardiac troponin T gene found in Japanese patient with hypertrophic cardiomyopathy
37. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene